Rypdal, K. B., Erusappan, P. M., Melleby, A. O., Seifert, D. E., Palmero, S., Strand, M. E., . . . Lunde, I. G. (2021). The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts. Nature Portfolio.
Chicago Style (17th ed.) CitationRypdal, Karoline B., et al. The Extracellular Matrix Glycoprotein ADAMTSL2 Is Increased in Heart Failure and Inhibits TGFβ Signalling in Cardiac Fibroblasts. Nature Portfolio, 2021.
MLA (8th ed.) CitationRypdal, Karoline B., et al. The Extracellular Matrix Glycoprotein ADAMTSL2 Is Increased in Heart Failure and Inhibits TGFβ Signalling in Cardiac Fibroblasts. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.